Darcy A Krueger Selected Research

trans-sodium crocetinate (crocetin)

1/2022	The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review.
1/2022	Prevalence of thoracoabdominal imaging findings in tuberous sclerosis complex.
1/2022	Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis.
1/2022	Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem).
12/2021	Symptom rates and profile clustering in tuberous sclerosis complex-associated neuropsychiatric disorders (TAND).
12/2021	Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite Study.
10/2021	Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations.
10/2021	Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex.
1/2021	Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports.
1/2021	Diabetes in Individuals With Tuberous Sclerosis Complex Treated With mTOR Inhibitors.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Darcy A Krueger Research Topics

Disease

47	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 01/2008
14	Epilepsy (Aura) 01/2022 - 01/2008
12	Astrocytoma (Pilocytic Astrocytoma) 01/2021 - 01/2008
11	Neoplasms (Cancer) 01/2022 - 01/2008
8	Autistic Disorder (Autism) 12/2021 - 01/2008
7	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 07/2015
7	Autism Spectrum Disorder 12/2021 - 07/2015
6	Angiomyolipoma 01/2022 - 12/2015
4	Hamartoma 12/2019 - 12/2015
3	Cysts 01/2022 - 08/2013
3	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2021 - 08/2013
3	Hydrocephalus (Hydrocephaly) 07/2017 - 11/2010
3	Seizures (Absence Seizure) 01/2017 - 02/2013
3	Disease Progression 11/2015 - 01/2008
2	Hyperplasia 01/2022 - 01/2021
2	Lung Diseases (Lung Disease) 01/2021 - 01/2008
2	Drug Resistant Epilepsy 12/2016 - 11/2013
2	Encephalitis (Encephalitis, Rasmussen) 01/2012 - 04/2011
1	Diabetes Mellitus 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021
1	Primitive Neuroectodermal Tumors (PNET) 01/2021
1	Sarcopenia 01/2020
1	Intellectual Disability (Idiocy) 01/2019
1	Infantile Spasms (West Syndrome) 12/2018
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Amenorrhea 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2017
1	Menstruation Disturbances 01/2017
1	Thrombocytopenia (Thrombopenia) 04/2015
1	Hypercholesterolemia 04/2015
1	Fatigue 04/2015
1	Stomatitis 02/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 02/2013
1	Sinusitis 02/2013
1	Otitis Media 02/2013
1	Sclerosis 02/2012
1	Vision Disorders (Hemeralopia) 02/2012
1	Ovarian Teratoma 01/2012
1	Teratoma (Teratoid Tumor) 01/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2008
1	Angiofibroma 01/2008

Drug/Important Bio-Agent (IBA)

41	trans-sodium crocetinate (crocetin)IBA 01/2022 - 01/2008
15	Everolimus FDA Link 01/2021 - 11/2010
11	TOR Serine-Threonine KinasesIBA 01/2021 - 01/2008
7	MTOR InhibitorsIBA 01/2021 - 11/2015
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
3	Sirolimus (Rapamycin)FDA Link 01/2021 - 12/2015
3	Vigabatrin FDA Link 12/2018 - 02/2012
2	lipoarabinomannan (LAM)IBA 01/2021 - 08/2013
2	Pharmaceutical PreparationsIBA 01/2019 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 07/2017 - 11/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2012 - 04/2011
1	LipidsIBA 01/2022
1	Vascular Endothelial Growth Factor DIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2018
1	Cytostatic AgentsIBA 10/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2017
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2017
1	ChromatinIBA 11/2015
1	Biological ProductsIBA 04/2015
1	Alanine Transaminase (SGPT)IBA 04/2015
1	cixutumumabIBA 04/2015
1	temsirolimus FDA Link 04/2015
1	N-Methylaspartate (NMDA)IBA 04/2011
1	Explosive Agents (Explosives)IBA 04/2011
1	SteroidsIBA 04/2011

Therapy/Procedure

8	Therapeutics 01/2021 - 01/2008
2	Aftercare (After-Treatment) 01/2017 - 02/2012
1	Operative Surgical Procedures 01/2021
1	Ventriculoperitoneal Shunt 07/2017
1	Ketogenic Diet 11/2015
1	Plasma Exchange 04/2011